This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goss, K. H. Articles by Groden, J. Search for Related Content PubMed PubMed Citation Articles by Goss, K. H. Articles by Groden, J.

Biology of the Adenomatous Polyposis Coli Tumor Suppressor

From the Howard Hughes Medical Institute, Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, OH.

Address reprint requests to Joanna Groden, PhD, Department of Molecular Genetics, College of Medicine, University of Cincinnati, 231 Bethesda Ave, Cincinnati, OH 45267; email joanna.groden{at}uc.edu

ABSTRACT

ABSTRACT: The adenomatous polyposis coli (APC) gene was first identified as the gene mutated in an inherited syndrome of colon cancer predisposition known as familial adenomatous polyposis coli (FAP). Mutation of APC is also found in 80% of all colorectal adenomas and carcinomas and is one of the earliest mutations in colon cancer progression. Similar to other tumor suppressor genes, both APC alleles are inactivated by mutation in colon tumors, resulting in the loss of full-length protein in tumor cells. The functional significance of altering APC is the dysregulation of several physiologic processes that govern colonic epithelial cell homeostasis, which include cell cycle progression, migration, differentiation, and apoptosis. Roles for APC in some of these processes are in large part attributable to its ability to regulate cytosolic levels of the signaling molecule beta-catenin and to affect the transcriptional profile in cells. This article summarizes numerous genetic, biochemical, and cell biologic studies on the mechanisms of APC-mediated tumor suppression. Mouse models of FAP, in which the APC gene has been genetically inactivated, have been particularly useful in testing therapeutic and chemopreventive strategies. These data have significant implications for colorectal cancer treatment approaches as well as for understanding other disease genes and cancers of other tissue types.

This article has been cited by other articles:

				R. Meza, J. Jeon, S. H. Moolgavkar, and E. G. Luebeck Age-specific incidence of cancer: Phases, transitions, and biological implications PNAS, October 21, 2008; 105(42): 16284 - 16289. [Abstract] [Full Text] [PDF]

				E. J. Groen, A. Roos, F. L. Muntinghe, R. H. Enting, J. de Vries, J. H. Kleibeuker, M. J. H. Witjes, T. P. Links, and A. P. van Beek Extra-Intestinal Manifestations of Familial Adenomatous Polyposis Ann. Surg. Oncol., September 1, 2008; 15(9): 2439 - 2450. [Abstract] [Full Text] [PDF]

				Z. Liu, S.-W. Choi, J. W. Crott, M. K. Keyes, H. Jang, D. E. Smith, M. Kim, P. W. Laird, R. Bronson, and J. B. Mason Mild Depletion of Dietary Folate Combined with Other B Vitamins Alters Multiple Components of the Wnt Pathway in Mouse Colon J. Nutr., December 1, 2007; 137(12): 2701 - 2708. [Abstract] [Full Text] [PDF]

				S. Signoroni, M. Frattini, T. Negri, E. Pastore, E. Tamborini, P. Casieri, M. Orsenigo, L. Da Riva, P. Radice, P. Sala, et al. Cyclooxygenase-2 and Platelet-Derived Growth Factor Receptors as Potential Targets in Treating Aggressive Fibromatosis Clin. Cancer Res., September 1, 2007; 13(17): 5034 - 5040. [Abstract] [Full Text] [PDF]

				N. M. Sodir, X. Chen, R. Park, A. E. Nickel, P. S. Conti, R. Moats, J. R. Bading, D. Shibata, and P. W. Laird Smad3 Deficiency Promotes Tumorigenesis in the Distal Colon of ApcMin/+ Mice. Cancer Res., September 1, 2006; 66(17): 8430 - 8438. [Abstract] [Full Text] [PDF]

				S.-J. Myung, R. M. Rerko, M. Yan, P. Platzer, K. Guda, A. Dotson, E. Lawrence, A. J. Dannenberg, A. K. Lovgren, G. Luo, et al. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis PNAS, August 8, 2006; 103(32): 12098 - 12102. [Abstract] [Full Text] [PDF]

				J. I. Fenton and N. G. Hord Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research Carcinogenesis, May 1, 2006; 27(5): 893 - 902. [Abstract] [Full Text] [PDF]

				M. B. Genter Molecular Biology of the Nasal Airways: How Do We Assess Cellular and Molecular Responses in the Nose? Toxicol Pathol, April 1, 2006; 34(3): 274 - 280. [Abstract] [Full Text] [PDF]

				R. J. Canter, S. B. Kesmodel, D. F. Heitjan, N. K. Veeramachaneni, N. A. Mokadam, J. A. Drebin, and D. L. Fraker Suppression of {beta}-Catenin by Antisense Oligomers Augments Tumor Response to Isolated Limb Perfusion in a Rodent Model of Adenomatous Polyposis Coli-Mutant Colon Cancer Ann. Surg. Oncol., September 1, 2005; 12(9): 733 - 742. [Abstract] [Full Text] [PDF]

				K. Steigerwald, G. K. Behbehani, K. A. Combs, M. C. Barton, and J. Groden The APC Tumor Suppressor Promotes Transcription-Independent Apoptosis In vitro Mol. Cancer Res., February 1, 2005; 3(2): 78 - 89. [Abstract] [Full Text] [PDF]

				A. E. Moran, D. H. Hunt, S. H. Javid, M. Redston, A. M. Carothers, and M. M. Bertagnolli Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice J. Biol. Chem., October 8, 2004; 279(41): 43261 - 43272. [Abstract] [Full Text] [PDF]

				M. M. Huycke and H. R. Gaskins Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models Experimental Biology and Medicine, July 1, 2004; 229(7): 586 - 597. [Abstract] [Full Text] [PDF]

				Z. Xiao, B. T. Luke, G. Izmirlian, A. Umar, P. M. Lynch, R. K. S. Phillips, S. Patterson, T. P. Conrads, T. D. Veenstra, P. Greenwald, et al. Serum Proteomic Profiles Suggest Celecoxib-Modulated Targets and Response Predictors Cancer Res., April 15, 2004; 64(8): 2904 - 2909. [Abstract] [Full Text] [PDF]

				S. C. C. Wong, E. S. F. Lo, K. C. Lee, J. K. C. Chan, and W. L. W. Hsiao Prognostic and Diagnostic Significance of {beta}-Catenin Nuclear Immunostaining in Colorectal Cancer Clin. Cancer Res., February 15, 2004; 10(4): 1401 - 1408. [Abstract] [Full Text] [PDF]

				S. H. Diks, J. C. Hardwick, R. M. Diab, M. M. van Santen, H. H. Versteeg, S. J. H. van Deventer, D. J. Richel, and M. P. Peppelenbosch Activation of the Canonical {beta}-Catenin Pathway by Histamine J. Biol. Chem., December 26, 2003; 278(52): 52491 - 52496. [Abstract] [Full Text] [PDF]

				G. Tarafa, E. Prat, R.-A. Risques, S. Gonzalez, J. Camps, M. Grau, E. Guino, V. Moreno, M. Esteller, J. G. Herman, et al. Common Genetic Evolutionary Pathways in Familial Adenomatous Polyposis Tumors Cancer Res., September 15, 2003; 63(18): 5731 - 5737. [Abstract] [Full Text] [PDF]

				T. Chen, I. Yang, R. Irby, K. H. Shain, H. G. Wang, J. Quackenbush, D. Coppola, J. Q. Cheng, and T. J. Yeatman Regulation of Caspase Expression and Apoptosis by Adenomatous Polyposis Coli Cancer Res., August 1, 2003; 63(15): 4368 - 4374. [Abstract] [Full Text] [PDF]

				M. B. Genter, D. M. Burman, S. Vijayakumar, C. L. Ebert, and B. J. Aronow Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa Physiol Genomics, December 26, 2002; 12(1): 35 - 45. [Abstract] [Full Text] [PDF]

				S. A. Lamprecht and M. Lipkin Migrating colonic crypt epithelial cells: primary targets for transformation Carcinogenesis, November 1, 2002; 23(11): 1777 - 1780. [Abstract] [Full Text] [PDF]

				R. Koratkar, E. Pequignot, W. W. Hauck, and L. D. Siracusa The CAST/Ei Strain Confers Significant Protection against ApcMin Intestinal Polyps, Independent of the Resistant Modifier of Min 1 (Mom1R) Locus Cancer Res., October 1, 2002; 62(19): 5413 - 5417. [Abstract] [Full Text] [PDF]

				C. B. Anderson, K. L. Neufeld, and R. L. White Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon PNAS, June 25, 2002; 99(13): 8683 - 8688. [Abstract] [Full Text] [PDF]

				K. Heppner Goss, C. Trzepacz, T. M. F. Tuohy, and J. Groden Attenuated APC alleles produce functional protein from internal translation initiation PNAS, June 11, 2002; 99(12): 8161 - 8166. [Abstract] [Full Text] [PDF]

				I. Chau and D. Cunningham Cyclooxygenase Inhibition in Cancer -- A Blind Alley or a New Therapeutic Reality? N. Engl. J. Med., April 4, 2002; 346(14): 1085 - 1087. [Full Text] [PDF]

				K. A. Silverman, R. Koratkar, L. D. Siracusa, and A. M. Buchberg Identification of the Modifier of Min 2 (Mom2) Locus, a New Mutation That Influences Apc-Induced Intestinal Neoplasia Genome Res., January 1, 2002; 12(1): 88 - 97. [Abstract] [Full Text] [PDF]

				H. Roh, D. W. Green, C. B. Boswell, J. A. Pippin, and J. A. Drebin Suppression of {beta}-Catenin Inhibits the Neoplastic Growth of APC-Mutant Colon Cancer Cells Cancer Res., September 1, 2001; 61(17): 6563 - 6568. [Abstract] [Full Text] [PDF]

				R A Sharma, A J Gescher, K J O'Byrne, and W P Steward Familiar drugs may prevent cancer Postgrad. Med. J., August 1, 2001; 77(910): 492 - 497. [Abstract] [Full Text] [PDF]

				N. S. Fearnhead, M. P. Britton, and W. F. Bodmer The ABC of APC Hum. Mol. Genet., April 1, 2001; 10(7): 721 - 733. [Abstract] [Full Text] [PDF]

				K. STEIGERWALD, I. M SANTORO, J. J KORDICH, V. GISMONDI, C. TRZEPACZ, M. BADIALI, F GIANGASPERO, M G. BALKO, J. S GRAHAM, N. RATNER, et al. A distinct splice form of APC is highly expressed in neurones but not commonly mutated in neuroepithelial tumours J. Med. Genet., April 1, 2001; 38(4): 257 - 262. [Full Text]

				M.-P. Gulli and M. Peter Temporal and spatial regulation of Rho-type guanine-nucleotide exchange factors: the yeast perspective Genes & Dev., February 15, 2001; 15(4): 365 - 379. [Full Text]

				A. S. Jaiswal and S. Narayan p53-dependent Transcriptional Regulation of the APC Promoter in Colon Cancer Cells Treated with DNA Alkylating Agents J. Biol. Chem., May 18, 2001; 276(21): 18193 - 18199. [Abstract] [Full Text] [PDF]